David Gaiero
Director of Finance/CFO at CYTEIR THERAPEUTICS, INC.
Net worth: 308 197 $ as of 2024-03-30
Profile
David Gaiero is currently the Chief Financial Officer & Treasurer at Cyteir Therapeutics, Inc. and the Chief Financial & Accounting Officer at Imunon, Inc. He is also a Partner at Monomoy Advisors LLC.
Previously, he held the position of Chief Financial & Accounting Officer at Wave Life Sciences Ltd.
and Vice President & Global Controller at OvaScience, Inc. Mr. Gaiero completed his undergraduate degree at the University of Massachusetts.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-03-03 | 102,391 ( 0.28% ) | 308 197 $ | 2024-03-30 |
David Gaiero active positions
| Companies | Position | Start |
|---|---|---|
| CYTEIR THERAPEUTICS, INC. | Director of Finance/CFO | 2020-11-30 |
| IMUNON, INC. | Director of Finance/CFO | 2024-05-31 |
| Monomoy Advisors LLC | Corporate Officer/Principal | - |
Former positions of David Gaiero
| Companies | Position | End |
|---|---|---|
| WAVE LIFE SCIENCES LTD. | Director of Finance/CFO | 2020-12-03 |
OvaScience, Inc.
 OvaScience, Inc. Pharmaceuticals: MajorHealth Technology OvaScience, Inc. engages in the research and development of female infertility treatments. Its portfolio includes AUGMENT, OvaPrime, OvaTure, and OvaXon which intends to improve the female's egg health and reserve. The company was founded by Rich H. Aldrich, Michelle Dipp, Jonathan L. Tilly, and Christoph H. Westphal on April 5, 2011 and is headquartered in Waltham, MA. | Comptroller/Controller/Auditor | 2016-12-31 |
Training of David Gaiero
| University of Massachusetts | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| IMUNON, INC. | Health Technology |
| WAVE LIFE SCIENCES LTD. | Health Technology |
| Private companies | 3 |
|---|---|
OvaScience, Inc.
OvaScience, Inc. Pharmaceuticals: MajorHealth Technology OvaScience, Inc. engages in the research and development of female infertility treatments. Its portfolio includes AUGMENT, OvaPrime, OvaTure, and OvaXon which intends to improve the female's egg health and reserve. The company was founded by Rich H. Aldrich, Michelle Dipp, Jonathan L. Tilly, and Christoph H. Westphal on April 5, 2011 and is headquartered in Waltham, MA. | Health Technology |
Cyteir Therapeutics, Inc.
 Cyteir Therapeutics, Inc. BiotechnologyHealth Technology Cyteir Therapeutics, Inc.is a clinical-stage biotechnology company, develops and commercializes the next-generation of precision oncology medicines. Its lead product CYT-0851, a novel, oral, once-daily, small molecule drug candidate that is in Phase I/II clinical trial for monotherapy in solid tumors and hematologic malignancies, as well as for combination therapy in solid tumors and hematologic malignancies. The company was founded by Kevin Mills and Timothy Romberger in June 2012 and is headquartered in Lexington, MA. | Health Technology |
| Monomoy Advisors LLC |
- Stock Market
- Insiders
- David Gaiero
